UK approves GlaxoSmithKline drug to treat Covid-19
LONDON, Dec 2, 2021 (AFP) – British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it “retains activity” against the new Omicron variant. The monoclonal antibody “was found to be safe and effective at reducing the risk of hospitalisation and death in … Read more